Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.76
23.11.20
-
23.11.21
157.64%
24.11.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Paul223 
23.11.20 50%
sell
Sony Corp

Start price
Target price
Perf. (%)
€76.39
23.11.20
-
23.11.21
6.70%
25.01.21

EBIT growth >5% per year expected
Differentiated customer and product portfolio
Small cyclical dependencies
Revenue growth >5% per year expected
SpringheelJack 
23.11.20 50%
sell
Sony Corp

Start price
Target price
Perf. (%)
€76.39
23.11.20
-
23.11.21
6.70%
25.01.21

EBIT growth >5% per year expected
Differentiated customer and product portfolio
Small cyclical dependencies
Revenue growth >5% per year expected
SpringheelJack 
23.11.20 50%
sell
Sony Corp

Start price
Target price
Perf. (%)
€76.39
23.11.20
-
23.11.21
6.70%
25.01.21

EBIT growth >5% per year expected
Differentiated customer and product portfolio
Small cyclical dependencies
Revenue growth >5% per year expected
SpringheelJack 
23.11.20 50%
sell
Sony Corp

Start price
Target price
Perf. (%)
€76.39
23.11.20
-
23.11.21
6.70%
25.01.21

EBIT growth >5% per year expected
Differentiated customer and product portfolio
Small cyclical dependencies
Revenue growth >5% per year expected
SpringheelJack 
23.11.20 50%
sell
Sony Corp

Start price
Target price
Perf. (%)
€76.39
23.11.20
-
23.11.21
6.70%
25.01.21

EBIT growth >5% per year expected
Differentiated customer and product portfolio
Small cyclical dependencies
Revenue growth >5% per year expected
SpringheelJack 
23.11.20 50%
sell
Sony Corp

Start price
Target price
Perf. (%)
€76.39
23.11.20
-
23.11.21
6.70%
25.01.21

EBIT growth >5% per year expected
Differentiated customer and product portfolio
Small cyclical dependencies
Revenue growth >5% per year expected
SpringheelJack 
23.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€485.05
23.11.20
€770.00
07.07.23
39.47%
25.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
RudolfL 
23.11.20 60%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€485.05
23.11.20
€770.00
07.07.23
39.47%
25.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
RudolfL 
23.11.20 60%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€485.05
23.11.20
€770.00
07.07.23
39.47%
25.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
RudolfL 
23.11.20 60%
buy
Plastic Omnium S.A.

Start price
Target price
Perf. (%)
€24.18
22.11.20
€28.00
22.11.21
0.17%
23.11.21

Could be worthwhile Investment >10% per year
melinda 
22.11.20 50%
buy
Energiekontor

Start price
Target price
Perf. (%)
€43.10
22.11.20
€60.00
22.11.21
89.33%
23.11.21

Could be worthwhile Investment >10% per year
melinda 
22.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
22.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
22.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
22.11.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.20
22.11.20
€73.00
22.11.21
-0.41%
23.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Very high dividend yield expected
Konrad 
22.11.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.20
22.11.20
€73.00
22.11.21
-0.41%
23.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Very high dividend yield expected
Konrad 
22.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

marge 
22.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

marge 
22.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

marge 
22.11.20 50%
buy
Citizens Financial

Start price
Target price
Perf. (%)
€27.20
21.11.20
-
21.11.21
15.44%
22.01.21

Revenue growth >5% per year expected
EBIT decline/stagnation expected
SpringheelJack 
21.11.20 50%
buy
Groupe SFPI S.A.

Start price
Target price
Perf. (%)
€1.66
21.11.20
€3.80
21.11.21
108.16%
24.10.21

Could be worthwhile Investment >10% per year
melinda 
21.11.20 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€8.95
21.11.20
-
21.11.21
28.49%
10.02.21

Could be worthwhile Investment >10% per year
High risks for its business
Dependend from few customers or products
Washer 
21.11.20 50%
buy
Apple Inc.

Start price
Target price
Perf. (%)
€99.28
20.11.20
€130.00
20.11.21
25.18%
21.07.21

Could be very worthwhile Investment >20% year
OKIAMD 
20.11.20 50%
buy
Apple Inc.

Start price
Target price
Perf. (%)
€99.28
20.11.20
€130.00
20.11.21
25.18%
21.07.21

Could be very worthwhile Investment >20% year
OKIAMD 
20.11.20 50%